Genmab A/S
Genmab A/S (GNMSF) Market Cap & Net Worth
Live market cap, enterprise value, and global rank — multi-year chart and annual table below.
gnmsf · market cap & enterprise value · FMP · as of Jun 5, 2026
Core market cap & key metrics
As of Jun 5, 2026, Genmab A/S (GNMSF) has a market cap — also referred to as its net worth or valuation — of $15.3B, making it one of the top most valuable companies globally. Market Cap = $249.45 × shares outstanding.
Market cap history — by year
* 2026 = year-to-date · Year-end market cap · Source: FMP
Market cap by year
Compared to Peers
View Healthcare sectorAbout Market Cap, Net Worth & Valuation
Genmab A/S (GNMSF) has a market cap — also referred to as its net worth or valuation — of $15.3B as of Jun 5, 2026, making it the #0 most valuable company globally. Market Cap = Stock Price × Shares Outstanding.
Genmab A/S reached its all-time high market cap of $194.1B on Dec 31, 2022. Comparing the Genmab A/S market cap history illustrates one of the most extraordinary corporate growth stories.
Investors frequently compare Genmab A/S net worth vs peers and ask how Genmab A/S valuation compares to other countries. Its market cap reflects continued investor confidence.
Frequently Asked Questions
GNMSF market cap · 6 questionsGenmab A/S's net worth — measured as market capitalization — is $15.3B as of Jun 5, 2026. It ranks #0 globally. Market Cap = $$249.45 (price) × shares outstanding.